Scott Moomaw sold $2.0M of Liquidia (LQDA)

Executed Sep 2 2025, disclosed Sep 3 2025, 1 day later.

Value, as filed

$2.0M

70,000 sh across 2 lots

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 3 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SM Scott Moomaw Chief Commercial Officer profile →

Scott Moomaw (Chief Commercial Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $2.8M of LQDA (80,000 sh × $35.32, as filed), executed Mar 9.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Scott Moomaw in LQDA

LQDASALE Liquidia Corporation $634K
8,864 sh × $71.52
Exec Jul 13
Filed Jul 14 · 8:01 PM ET LQDASALE Liquidia Corporation $340K
8,861 sh × $38.37
Exec Apr 13
Filed Apr 14 · 5:30 PM ET LQDASALE Liquidia Corporation $626K
17,000 sh × $36.81
Exec Mar 23
Filed Mar 25 · 5:30 PM ET LQDASALE Liquidia Corporation $2.8M
80,000 sh × $35.32
Exec Mar 9
Filed Mar 11 · 5:30 PM ET LQDASALE Liquidia Corporation $769K
20,533 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET LQDASALE Liquidia Corporation $115K
4,900 sh × $23.41
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET LQDASALE Liquidia Corporation $113K
6,656 sh × $16.97
Exec Jun 4 2025
Filed Jun 5 2025 · 5:30 PM ET